Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, November 10, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant
Life Sciences Times
-
November 10, 2025
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Merz Aesthetics® Expands Upon NEOCUTIS® Skincare Line with Launch of New ‘Neo Restore Post Treatment Nourishing Sheet Mask’
Life Sciences Times
-
August 31, 2023
0
Pharma
Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID
Life Sciences Times
-
August 29, 2023
0
Pharma
U.S. FDA Approves Bristol Myers Squibb’s Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
Life Sciences Times
-
August 29, 2023
0
Pharma
Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH’s National Institute on Drug Abuse to Advance Cebranopadol for the Treatment of...
Life Sciences Times
-
August 28, 2023
0
Pharma
Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis
Life Sciences Times
-
August 16, 2023
0
Pharma
The Access to Advanced Health Institute Receives $18 Million Award to Develop a Temperature Stable, Single-Dose Chikungunya RNA Vaccine Through a Phase 1 Clinical...
Life Sciences Times
-
August 3, 2023
0
Pharma
U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
Life Sciences Times
-
August 3, 2023
0
Pharma
AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulatory AVM0703 through Expanded Access/Compassionate Use Programs
Life Sciences Times
-
August 1, 2023
0
Pharma
FDA Approves Harm Reduction Therapeutics’ Over-the-Counter Opioid Overdose Reversal Medication
Life Sciences Times
-
August 1, 2023
0
Pharma
Melinta Therapeutics Announces Commercial Availability of REZZAYO™
Life Sciences Times
-
July 31, 2023
0
Pharma
Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease
Life Sciences Times
-
July 25, 2023
0
Pharma
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
Life Sciences Times
-
July 14, 2023
0
1
...
30
31
32
...
83
Page 31 of 83
Most Read
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
November 10, 2025
Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals
November 10, 2025
Dr. Nina Kottler Named Chief Medical AI Officer of Mosaic Clinical Technologies
November 10, 2025
Kaneka Expands Global Availability of i-ED Coil with European Launch
November 10, 2025